The CNS abundantly expresses P2X receptor channels for ATP; of these the most widespread in the brain is the P2X 4 channel. We show that ivermectin (IVM) is a specific positive allosteric effector of heterologously expressed P2X 4 and possibly of heteromeric P2X 4 /P2X 6 channels, but not of P2X 2 , P2X 3 , P2X 2 / P2X 3, or P2X 7 channels. In the submicromolar range (EC 50, ϳ250 nM) the action of IVM was rapid and reversible, resulting in increased amplitude and slowed deactivation of P2X 4 channel currents evoked by ATP. IVM also markedly increased the potency of ATP and that of the normally low-potency agonist ␣,␤-methylene-ATP in a use-and voltage-independent manner without changing the ion selectivity of P2X 4 channels. Therefore, IVM evokes a potent pharmacological gain-of-function phenotype that is specific for P2X 4 channels. We also tested whether IVM could modulate endogenously expressed P2X channels in the adult trigeminal mesencephalic nucleus and hippocampal CA1 neurons. Surprisingly, IVM produced no significant effect on the fast ATP-evoked inward currents in either type of neuron, despite the fact that IVM modulated P2X 4 channels heterologously expressed in embryonic hippocampal neurons. These results suggest that homomeric P2X 4 channels are not the primary subtype of P2X receptor in the adult trigeminal mesencephalic nucleus and in hippocampal CA1 neurons.
The CNS abundantly expresses P2X receptor channels for ATP; of these the most widespread in the brain is the P2X 4 channel. We show that ivermectin (IVM) is a specific positive allosteric effector of heterologously expressed P2X 4 and possibly of heteromeric P2X 4 /P2X 6 channels, but not of P2X 2 , P2X 3 , P2X 2 / P2X 3, or P2X 7 channels. In the submicromolar range (EC 50, ϳ250 nM) the action of IVM was rapid and reversible, resulting in increased amplitude and slowed deactivation of P2X 4 channel currents evoked by ATP. IVM also markedly increased the potency of ATP and that of the normally low-potency agonist ␣,␤-methylene-ATP in a use-and voltage-independent manner without changing the ion selectivity of P2X 4 channels. Therefore, IVM evokes a potent pharmacological gain-of-function phenotype that is specific for P2X 4 channels. We also tested whether IVM could modulate endogenously expressed P2X channels in the adult trigeminal mesencephalic nucleus and hippocampal CA1 neurons. Surprisingly, IVM produced no significant effect on the fast ATP-evoked inward currents in either type of neuron, despite the fact that IVM modulated P2X 4 channels heterologously expressed in embryonic hippocampal neurons. These results suggest that homomeric P2X 4 channels are not the primary subtype of P2X receptor in the adult trigeminal mesencephalic nucleus and in hippocampal CA1 neurons.
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ATP f unctions as a neurotransmitter in the nervous system (Burnstock, 1972) , in which it can mediate (Edwards et al., 1992; Evans et al., 1992; Bardoni et al., 1997; Nieber et al., 1997; Pankratov et al., 1998; Jo and Schlichter, 1999) and possibly modulate fast synaptic transmission Khakh and Henderson, 1998a) . Furthermore, a class of ion channels exists that is a major target for synaptically released ATP; these are the P2X receptor channels. P2X receptors are ATPgated, nonselective cation channels , and they comprise a family of seven distinct subunits that can form functional channels when heterologously expressed (for review, see North, 1996; Ralevic and Burnstock, 1998) . Of these, P2X 4 receptor channels are notable because they are widely expressed in the brain Collo et al., 1996) , they form functional channels that can be both homomeric and heteromeric Collo et al., 1996; Seguela et al., 1996; Soto et al., 1996; Le et al., 1998a) , and they clearly can be localized to certain neurons (Le et al., 1998b) . P2X 4 receptors have thus been presumed to be an important target for endogenously released ATP. However, previously there has been no way to specifically probe P2X 4 channels, and this represented a considerable hindrance to investigating both their existence and pathophysiological roles in native systems. As a consequence, the prevalence and function of P2X 4 channels in brain neurons remained largely uninvestigated.
Many ligand-gated ion channels are allosterically modulated (Li et al., 1997; Changeux and Edelstein, 1998) , and such allosteric interactions can be starting points for rational drug design. Moreover, some P2X receptor channels are modulated by cations, e.g., P2X 2 and P2X 3 channels by Zn 2ϩ , Ca 2ϩ
, and H ϩ (King et al., 1997; Stoop et al., 1997; Wildman et al., 1997 Wildman et al., , 1998 Cook et al., 1998) . There is also evidence that an allosteric interaction at P2X 4 channels regulates agonist binding (Michel et al., 1997) , and recent work demonstrates that ATP receptor antagonists can also potentiate ATP-evoked currents at P2X 4 channels (Bo et al., 1995; Miller et al., 1998) ; however, the mechanism(s) and consequences for P2X 4 channel properties remain to be fully explored. Furthermore, such compounds are of limited value to probe P2X 4 channels, because they are antagonists of most other ATP receptors, they potently inhibit ATP-hydrolyzing enzymes, and some are chemically impure (see Humphrey et al., 1995) .
Ivermectin (IVM) is an agonist of glutamate-gated chloride channels of invertebrates from several phyla (Cully et al., 1994) , and this is thought to be its mechanism of action when used clinically as a treatment for river blindness caused by the nematode Onchocerca volvulus (Fisher and Mrozik, 1992; Van Laethem and Lopez, 1996) . Recent evidence shows that in addition to its action on glutamate-gated chloride channels, IVM can also allosterically modulate mammalian GABA A (Krusek and Zemkova, 1994) and ␣ 7 nicotinic channels (Krause et al., 1998) , and this prompted us to test its actions on P2X channels.
MATERIALS AND METHODS
Molecular biolog y. Wild-type P2X 2 , P2X 3 , P2X 4 , and P2X 7 cDNAs cloned into pcDNA3 or pcDNA1 were obtained from Glaxo Wellcome (Greenford, Middlesex, UK). cDNAs were linearized at unique restriction sites downstream of the poly(A) tail. The cDNAs were transcribed in vitro using the mM ESSAGE mM ACHI N E kit (Ambion Inc., Austin, TX). The capped cRNA was dissolved in DEPC -treated water at a concentration of ϳ1 g/l and stored at Ϫ80°C until required in 2 l aliquots. Five to 10 ng of cRNA were injected into individual Xenopus laevis oocytes in a volume of 50 nl /oocyte using a Drummond micropipettor (Quick and Lester, 1994) ; the preparation and maintenance of the oocytes was performed as described previously (Quick and Lester, 1994) , and all electrophysiological recordings were made 1-4 d after injection.
Ooc yte studies. T wo-electrode voltage-clamp recording of oocytes was performed using the Geneclamp 500 amplifier (Axon Instruments, Foster C ity, CA). Electrodes were pulled (Flaming-Brown type horizontal puller; Sutter Instruments, Novato, CA) from borosilicate glass (Sutter Instruments) and back-filled with 3 M KC l to yield resistances of 1-2 M⍀. Recordings were made in solution consisting of (in mM): 98 NaC l, 5 H EPES, and 1 MgC l 2 , pH 7.45, which was superf used over the oocytes by gravity flow at a rate of ϳ3 ml /min (chamber volume was ϳ300 l). Solutions containing ATP were applied to the oocyte using a solenoidoperated solution switcher (General Valve Co., Fairfield, NJ); complete solution exchange around the oocyte occurred within 0.5-1.0 sec. We used IV M at a concentration of Յ10 M, because at higher concentrations we occasionally observed some precipitation in physiological solutions. The vehicle for IV M is DMSO. In vehicle controls 1% DMSO did not affect ATP-evoked currents (control 100 M ATP-evoked current was Ϫ2611 Ϯ 186 nA, whereas in the presence of 1% DMSO it was Ϫ2789 Ϯ 69 nA; p Ͼ 0.05; n ϭ 4; also see Results). Voltage control of oocytes was maintained using a Digidata 1200 interface and a personal computer running pCL AM P 6 or pCL AM P 7 software (Axon Instruments). Data were filtered at 200 -500 Hz and digitized at three to five times this rate. Current-voltage relation data were filtered at 1 kHz and digitized at 3 kHz. All experiments were performed at 20 -23°C.
Human embr yonic k idney cells. Human embryonic kidney (H EK) 293 cells were transfected using Superfect (Qiagen, Hilden, Germany), and all recordings were made 24 -48 hr later using an Axoclamp 2A amplifier (Axon Instruments). The extracellular recording solution used for mammalian cells comprised (in mM): 147 NaC l, 2 KC l, 1 MgC l 2 , 2.5 CaCl 2 , 10 H EPES, and 10 dextrose, and the pipette solution comprised (in mM): 154 NaC l (or KC l), 11 EGTA, and 10 H EPES. Whole-cell voltage-clamp recordings were made with 5 M⍀ borosilicate glass electrodes (Sutter Instruments) using methods that are essentially identical to those already described (Evans et al., 1996) .
Adult rat brain slices. All methods used were similar to those already described previously for brainstem neurons (K hakh et al., 1997; K hakh and Henderson, 1998a,b) and hippocampal neurons (Dunwiddie et al., 1997; Frazier et al., 1998a,b) . Briefly, young (18-to 27-d-old) male Sprague Dawley rats were killed by decapitation, and a vibratome (model 1000; Pelco, C lovis, CA) was used to prepare 300-m-thick coronal slices of hippocampus and brainstem. During incubation the slices were submerged at 32-34°C in artificial C SF comprising (in mM): 124 NaC l, 3.3 KC l, 2.4 MgSO 4 , 10 D-glucose, 2.5 C aC l 2 , 1.2 K H 2 PO 4 , and 25.9 NaHC O 3 saturated with 95% O 2 and 5% C O 2 gas. All experiments were performed at 32-34°C while the tissue was superf used with buffer at a rate of 2 ml /min. Whole-cell patch-clamp recording was accomplished by using glass pipettes pulled using a Flaming-Brown electrode puller. The resistance of the pipettes was 6 -10 M⍀ when filled with a potassium gluconate-based internal solution, which comprised (in mM): 130 K gluconate, 1 EGTA, 2 MgC l 2 , 0.5 CaCl 2 , 2.5 ATP, 0.3 GTP, and 10 H EPES, pH 7.25, adjusted to 290 mOsm. C ells were visualized with an upright microscope (AxioSkop; Z eiss, Thornwood, N Y) equipped with differential interference contrast optics. Puffs (5-20 msec) of ATP (50 M) were applied directly to the cell body via pressure microejection (5-20 psi) from pipettes identical to the recording pipettes, using a Picospritzer II (General Valve, Fairfield, NJ) . Inward currents were recorded in neurons voltage-clamped at Ϫ50 to Ϫ60 mV using H EK A (Aalen, Germany) software and hardware. C alibrated syringe pumps (Razel, Stamford, C T) were used to add IV M from a concentrated stock solution directly to the superf usion system. Trigeminal mesencephalic nucleus (M N V) neurons were identified by their location (lateral to the locus coeruleus and the fourth ventricle), large pseudomonopolar appearance, and prominent I H current (K hakh et al., 1997; K hakh and Henderson, 1998b) . CA1 pyramidal cells were identified on the basis of their anatomical location, long dendrite projecting into the stratum radiatum, and distinctive electrophysiological characteristics (Dunwiddie et al., 1997; Frazier et al., 1998a,b) .
Embr yonic hippocampal neurons. Neurons were prepared as described (Li et al., 1998) . Hippocampal neuron cultures were transfected with plasmids for P2X 4 and for enhanced green fluorescent protein (EGFP) using the Bio-Rad (Hercules, CA) Helios gene gun. Gold particles coated with plasmids were prepared as recommended by the manufacturer, and the gene gun was pressurized between 60 and 100 psi. Neurons were transfected after 14 d in culture, and recordings were made 24 -48 hr later. Recordings were made using borosilicate glass electrodes of 4 -7 M⍀ resistance. The bath solution was (in mM): 110 NaC l, 5.4 KC l, 1.8 CaCl 2 , 0.8 MgC l 2 , 10 H EPES, and 10 D-glucose, pH 7.4, osmolarity 230 mOsm. Patch pipettes were filled with a solution containing (in mM): 100 potassium gluconate, 0.1 C aC l 2 , 1.1 EGTA, 5 MgC l 2 , 10 H EPES, 3 ATP, 3 phosphocreatine, and 0.3 GTP, pH 7.2, 215 mOsm. Whole-cell voltage clamp was maintained using an Axopatch-1D amplifier controlled by a personal computer running pCL AM P 6 software via a Digidata 1200 interface (Axon Instruments). Data were filtered at 2 kHz, digitized at 5 kHz, and recorded on computer for later analysis. Drugs were applied to single voltage-clamped neurons using a U-tube concentration clamp system (K hakh et al., 1995a,b) .
Data anal ysis. Data were analyzed using C lampfit (Axon Instruments) or Origin 5.0 (Microcal Software Inc., Northampton, M A). Data in the text and graphs are shown as mean Ϯ SEM from n determinations as indicated (always more than four experiments). All current-voltage relations shown in the figures are leak-subtracted. The ratio of NMDG ϩ to Na ϩ permeability was calculated for control ATP-evoked currents and those in the presence of IV M using the relation,
where pNMDG ϩ is the permeability to NMDG ϩ , pNa ϩ is the permeability to Na ϩ , ⌬E rev is the shift in reversal potential, and F, R, and T have their usual meaning (K hakh et al., 1999) . Concentration -effect curves were fitted where appropriate, as indicated, to the Hill equation of the form,
where y is current evoked by ATP, EC 50 is the response producing 50% of the maximal response, n H is the Hill coefficient, and [A] is the concentration of ATP. Membrane capacitance was determined from the capacitive transients produced by 5-10 mV steps of Ͼ200 msec duration using the membrane test capability of pCL AM P 7 (Axon Instruments). Mean data in Figure 3A were fitted to exponential f unctions (Origin 5.0) to determine time constants for association ( on ) and dissociation ( off ). The equilibrium dissociation constant (k d ) for the receptor-IV M interaction was determined by considering the interaction of IV M with P2X 4 channels by the following reaction scheme:
where the forward binding rate constant is k ϩ1 , [A] is the concentration of IV M used, and k Ϫ1 is the rate constant for dissociation. Total charge transfer during ATP-evoked currents was determined by integration of the voltage-clamp records. In some of the figures background noise has been minimized in the original traces by use of a Savitsky -Golay digital smoothing paradigm (Origin 5.0). Statistical tests were performed using the paired or unpaired Student's t test, as appropriate, and p Ͻ 0.05 was taken to indicate significance.
RESULTS
IVM potentiates P2X 4 but not P2X 2 , P2X 3 , P2X 2 /P2X 3 , or P2X 7 channel currents
We expressed homomeric P2X 4 channels in Xenopus oocytes and tested for responses to ATP applications (5-20 sec in duration). Suramin (30 M), which is an antagonist of some types of P2X ATP receptors, did not inhibit peak currents evoked by 100 M ATP at P2X 4 channels (n ϭ 4). However, suramin blocked by Ͼ80% the current evoked by 100 M ATP at both P2X 2 and P2X 3 channels ( Fig. 1 ; also see Buell et al., 1996; Seguela et al., 1996) . We next tested the action of IV M (10 M) on currents evoked by ATP (100 M) at P2X 2 , P2X 3 , P2X 2 / P2X 3 , P2X 4 , and P2X 7 channels. In cells expressing P2X 2 , P2X 3 , or P2X 2 / P2X 3 channels, IVM produced no significant effect on ATP-evoked currents (Fig.  1) ; however, in P2X 4 -expressing cells, IV M increased the peak ATP-evoked current significantly in all cells tested (by 50 -300% depending on the concentration and incubation time; see below). ATP-evoked currents at P2X 7 channels expressed in oocytes have two phases (Nuttle and Dubyak, 1994; K hakh et al., 1999) , and we tested whether IV M could affect either phase of these currents evoked by ATP at P2X 7 channels. Neither phase of the 100 M ATP-evoked current at P2X 7 channels was potentiated by IVM (10 M); the initial current and secondary current peaks were Ϫ512 Ϯ 76 and Ϫ7490 Ϯ 538 nA for ATP alone and Ϫ371 Ϯ 108 and Ϫ5257 Ϯ 945 nA for ATP plus IV M, respectively (n ϭ 3; unpaired Student's t test, p Ͼ 0.05). Homomeric P2X 1 and P2X 5 channel assemblies were not tested for IV M sensitivity.
Functional consequences of P2X 4 channel allosteric modulation IVM (3 M) produced a maximal potentiation of ATP-evoked currents at P2X 4 channels within 30 sec of application with a time constant ( on ) of 14 sec (Fig. 2 A; the apparent bimolecular rate constant for association was 2.2 ϫ 10 4 M/sec). The potentiation by IVM was fully reversible within 10 min of washing with a time constant ( off ) of 165 sec. The data presented in Figure 2 show that the action (and reversal) of IVM is use-independent, suggesting that permeation through open P2X channels is not required. The action of IVM depends on concentration, with an apparent half-maximal effect (EC 50 ) at ϳ257 nM (for currents evoked by 3 M ATP), which is in good agreement with a k d of 278 nM determined from kinetic experiments shown in Figure 2 , A and B (see Data analysis). However, the IVM concentrationeffect relationship did not reach a well defined plateau at high concentration (Fig. 2C) , vitiating a systematic description in terms of the Hill function or other dose-response formulations. With IVM at concentrations Ն10 M we observed a downward phase of the concentration-effect relationship, and this may represent increased desensitization of P2X 4 channels during ATP application. Importantly, the augmentation by IVM is not attributable to DMSO, because DMSO caused no marked change in the ATPevoked current when it was added to the buffer at 0.1% (control current evoked by ATP was Ϫ181 Ϯ 54 nA, whereas in the presence of DMSO it was Ϫ167 Ϯ 91 nA), but 1 M IVM solutions also contained 0.1% DMSO and produced a large increase in ATP-evoked current (Fig. 2C) .
In control cells P2X 4 channels responded to ATP with an EC 50 of 3 M (Khakh et al., 1999) , with a maximal current of ϳ2 A. However, in oocytes pretreated with 3 M IVM for 2 min before each application of ATP, the EC 50 was 0.3 M, and the maximal current increased to ϳ4 A (Fig. 2 D) . This profile of action is similar to the effect of IVM on ␣7 nicotinic channels (Krause et al., 1998) and indicates an allosteric action on P2X 4 channels.
We tested for voltage dependence for the action of IVM, as would be expected if its site of action were inside the pore. The data show that IV M does not cause any shift in the reversal potential of the ATP-evoked current-voltage relationship and that the IV M potentiation occurs at all membrane voltages (Ϫ120 to ϩ 60 mV with 3 M IV M and 10 or 100 M ATP; Fig. 2 E) . Figure 2 F shows these data plotted as a ratio of the IVMpotentiated current to the ATP-evoked current alone versus membrane potential. Although the potentiating effect of IVM clearly occurs at all membrane potentials, it does in addition display weak voltage dependence; the effect is smaller at voltages negative to Ϫ60 mV than at voltages more positive than this. In addition to increasing the peak current mediated by P2X 4 channels, IV M also increased the decay time of the ATP-evoked currents at P2X 4 channels by ϳ30-fold (Fig. 3 A, C) . This suggests that IV M increases the affinity of P2X 4 channels for ATP, and that once bound in the presence of IV M, ATP dissociates slowly from the channel. Alternatively P2X 4 channels may be less likely to enter a desensitized state after IV M application. We also determined the effect of IV M on total charge transfer during ATP-evoked currents; this was increased markedly (36 Ϯ 8-fold) by IVM from 4.1 Ϯ 0.8 C in control to 149 Ϯ 37 C with IVM. There was no change in membrane capacitance (Fig. 3D) during IVM application, suggesting that the effect of IV M on the peak ATP-evoked currents is probably not attributable to the insertion of vesicles containing a new population of P2X 4 channels. Instead the increase in peak ATP-evoked current, slowing of deactivation, and decrease in EC 50 for ATP are most readily explained by modulation of the existing population of P2X 4 channels.
The ATP analog ␣,␤-methylene-ATP is a weak agonist at P2X 4 channels, producing Ͻ10% of the current evoked by ATP (Fig.  4 A) even at high concentrations Seguela et al., 1996; Michel et al., 1997; Le et al., 1998a) , indicating that it is a low-efficacy agonist (Colquhoun, 1998 ). An allosteric effector acts independently of the agonist binding site and would therefore be expected to affect both ATP and ␣,␤-methylene-ATP responses. Indeed, IVM (3 M) increased the inward current evoked by 30 M ␣,␤-methylene-ATP significantly from Ϫ15 Ϯ 6 nA with ␣,␤-methylene-ATP alone to Ϫ357 Ϯ 147 nA for ␣,␤-methylene-ATP plus IVM (n ϭ 5); on the same occasions as these experiments were performed, IVM (3 M) increased the current evoked by ATP (30 M) from Ϫ273 Ϯ 75 to Ϫ857 Ϯ 284 nA (n ϭ 5). These data prompted us to investigate the action of IVM (3 M) on the concentration-effect relationship of ␣,␤-methylene-ATP. IVM converted ␣,␤-methylene-ATP from a weak agonist with an EC 50 of Ͼ300 M to a more potent agonist, one with an EC 50 of 19 M (Fig. 4 A) , and thus provides direct evidence for allosteric modulation of P2X 4 channels by IVM. The ratio of the IVM potentiated current to that of the ATP-evoked current alone is plotted versus the membrane voltage. IVM can potentiate the ATP-evoked current at all membrane voltages tested; in addition, the potentiation is slightly greater at positive voltages. For this figure the data are plotted as mean Ϯ SEM.
Channels formed by co-expression of P2X 4 and P2X 6 channels
We found no evidence for ATP-evoked or ␣,␤-methylene-ATPevoked currents at homomeric P2X 6 channels expressed in oocytes (with or without 3 M IV M), and this indicates that P2X 6 channels are nonf unctional in oocytes (also see Le et al., 1998a) . However, in agreement with previous data when P2X 4 and P2X 6 channels were co-expressed, we observed ␣,␤-methylene-ATPevoked currents with a threshold concentration of 10 M, and EC 50 of 25 M (Table 1) . The heteromeric P2X 4 / P2X 6 channel displays a phenotype distinct from either P2X 4 or P2X 6 channels alone (Le et al., 1998a) ; in particular, the threshold concentration for ␣,␤-methylene-ATP at P2X 4 channels was 300 M (Fig. 4 A, Table 1 ), indicating that the heteromer formed by co-expression of P2X 4 and P2X 6 channels has a higher sensitivity to ␣,␤-methylene-ATP than does homomultimeric P2X 4 alone (Le et al., 1998a) . We next tested the action of 3 M IV M in cells expressing P2X 4 /P2X 6 channels. In the most important observation, IVM decreased the ␣,␤-methylene-ATP threshold concentration from 10 to 3 M (Fig. 4 B, asterisk) . Because homomeric P2X 4 channels do not respond detectably to 3 M ␣,␤-methylene-ATP, this observation suggests-but does not prove -that IV M also potentiates a distinct receptor species, presumably the P2X 4 /P2X 6 receptor.
In oocytes co-injected with P2X 4 and P2X 6 mRNA, IVM also potentiated agonist-evoked currents at ␣,␤-methylene-ATP concentrations Ͼ10 M and decreased the EC 50 from 25 to 16 M (Table 1) . These IV M actions could arise via effects at homomeric P2X 4 channels that may also be present in the oocytes (Fig.  4, Table 1 ) and are therefore less convincing than the differences in threshold ␣,␤-methylene-ATP concentration.
IVM modulates only the I 1 states of P2X 4 channels
Recent data show that P2X 4 channels display biphasic currents during prolonged ATP applications in Na ϩ solutions (Fig. 5, I 1 ,  I 2 ). The second phase is attributable to a history-dependent increase in permeability (Khakh et al., 1999; Virginio et al., 1999) . We tested whether IVM modulates both I 1 and I 2 , and found that only the initial ATP-evoked current (I 1 , 10 -20 sec ATP applications), is potentiated (Fig. 5) . This provides further evidence that I 2 occurs independently of the magnitude of inward current during I 1 (Khakh et al., 1999 ). However, it remained possible that the potentiated I 1 current was in fact caused by a recruitment of some channels from the I 2 state, such that they now opened with brief ATP applications. To address this directly, we determined NMDG ϩ permeability ratios for the control and IVM-potentiated currents, because NMDG ϩ is substantially permeable during the I 2 current, and is only weakly permeable during I 1 . The reversal potential for ATP-evoked current alone (I 1 ) was Ϫ50.5 mV, whereas that for the IVM-potentiated current was Ϫ47.9 mV (see Fig. 5 ; n ϭ 5). In comparison, the reversal potential for I 2 is typically Ϫ30 mV (Khakh et al., 1999) . The pNMDG ϩ /pNa ϩ ratios for control ATP-evoked currents and the IVM-potentiated currents were identical (Fig. 5D ). This indicates that control currents and IVM-enhanced currents have equally low permeability to NMDG ϩ . Therefore, the previously reported low-selectivity I 2 state (Khakh et al., 1999) does not contribute detectably to the IVM-potentiated current; IVM potentiates only I 1 . The mechanism(s) of ion selectivity changes are not fully understood but likely involve structural rearrangements in the permeation pathway (Khakh et al., 1999; Virginio et al., 1999) . We presume that IVM binds less strongly to the I 2 state than to the I 1 state or does not enhance the conformational change that leads to opening of this state. This extends previous findings demonstrating that the distinct selectivity states of P2X 7 channels can be probed differentially by blockers (for review, see Ralevic and Burnstock, 1998) .
Allosteric modulation in a clonal mammalian cell line
To circumvent desensitization we applied ATP every 2 min to HEK 293 cells transfected with P2X 4 channels. After three doses of ATP we applied IVM (3 M) for 4 min and repeated the ATP applications. These experiments show that IVM can augment ATP-evoked currents in P2X 4 -transfected mammalian cells. The peak effect and kinetics resemble those observed for IVM action in oocytes, demonstrating that the effect of IVM on P2X 4 channels is independent of the host cell ( Fig. 6 ; top graph is from a single HEK 293 cell; bottom graph is an average from four such cells).
Brainstem and hippocampal neurons expressing P2X channels
The brainstem MNV contains proprioceptive neurons that express transcripts for P2X 4 , P2X 5 , and P2X 6 ; P2X responses are recorded on MNV neuron somata and central terminals (Cook et al., 1997; Khakh et al., 1997; Khakh and Henderson, 1998a) . In agreement with these studies, ATP (50 M) puffed directly onto the somata evoked inward currents in these neurons, but IVM (5 M) did not affect these ATP-evoked currents (Ͻ5% change; n ϭ 3; Fig. 7 ). These data provide further evidence that the P2X channels in MNV neurons do not comprise homomeric P2X 4 channels and thus extend previous findings using electrophysiological approaches (Cook et al., 1997; Khakh et al., 1997) . Recent studies in CA1 pyramidal neurons have demonstrated rapid ATP-evoked currents and fast ATP synaptic transmission (Pankratov et al., 1998; Proctor and Dunwiddie, 1998) , but the identity of the P2X channels in CA1 neurons is uncertain, in part because they express many mRNA species, including P2X 4 . If IV M could modulate the ATP-evoked currents in these neurons, this might indicate the presence of homomeric P2X 4 or possibly P2X 4 -containing channels. However, when responses to locally applied ATP were recorded from identified hippocampal CA1 pyramidal neurons, ATP-evoked currents in the majority of neurons were unaffected by IV M (13 of 13 neurons responded to ATP, but 10 of these 13 did not respond to IVM; Fig. 7) . A potential concern in these experiments was the possibility that IV M does not penetrate brain slices effectively. However, in parallel experiments we found that 2 M IVM markedly potentiated fast GABA A channel currents evoked by puffing GABA on to CA1 neurons; the effect of IV M was both rapid and reversible (n ϭ 3), suggesting that IV M does in fact penetrate brain slices. In three neurons we observed larger ATPevoked currents in the presence of IV M than in control. However when the data from all 13 cells were averaged, the increase was not significant (174 Ϯ 85% of control). To gain further insight as to the nature of the P2X channels expressed on CA1 neurons and to allow comparison with other neurons, we next tested the action of ␣,␤-methylene-ATP. ␣,␤-Methylene-ATP is a weak agonist at homomeric P2X 4 channels (Fig. 4 A) but is a potent agonist at known CNS heteromeric channels (Le et al., 1998a; Torres et al., 1998) ; it is known to activate P2X channels that are endogenously expressed in neurons, some of which are most likely heteromeric assemblies [e.g., sensory neurons (Chen et al., 1995; Khakh et al., 1995a; Lewis et al., 1995; Cook et al., 1997) , medial habenula neurons (Edwards et al., 1992) , and locus coeruleus neurons (Nieber et al., 1997) ]. When we puffed ␣,␤-methylene-ATP (50 M) onto CA1 neurons we observed large fast inward currents (Ϫ98 Ϯ 19 pA; six of six neurons). This observation, in combination with the lack of effect of IVM on most cells, provides the first functional evidence to indicate that homomeric P2X 4 channels are not expressed in the majority of adult hippocampal CA1 region neurons, despite the fact that in situ hybridization studies show that their transcripts are abundant here ; Figure 4 . Effect of ␣,␤-methylene-ATP on homomeric P2X 4 and heteromeric P2X 4 / P2X 6 channels. A, P2X 4 channels: concentration-effect curves for ␣,␤-methylene-ATP in the absence and presence of 3 M IVM. Right graphs, Same data on an expanded current scale. B, Co-expression of P2X 4 / P2X 6 channels: concentration-effect curves for ␣,␤-methylene-ATP in the absence and presence of 3 M IVM. Right graphs, Same data on an expanded current scale. The asterisks indicate the threshold concentration for ␣,␤-methylene-ATP (see Table 1 ). a I max is the largest current on the concentration-effect curve to ␣,␤-methylene-ATP (100 or 300 M). b The Hill slope was not possible to determine.
*Statistical difference (at p Ͻ 0.05) between these two EC 50 values ( p ϭ 0.005; unpaired Student's t test; also see Figure 4 for graphs). Collo et al., 1996) ; overall this supports and extends previous findings using immunocytochemistry (Le et al., 1998a) . Conclusions about the lack of effect of IV M against ATPevoked currents in brain slice neurons would be invalid if for unknown reasons IV M does not modulate P2X 4 channels when expressed in neurons. To address this directly we transfected embryonic hippocampal neurons with P2X 4 and used EGFP as a transfection reporter. Untransfected neurons show no ATPevoked responses (Fig. 8C,D, top; 0.1-1 mM ATP), consistent with in situ hybridization studies showing minimal levels of P2X 4 transcripts in the embryonic hippocampus . We used the presence of EGFP fluorescence (24 -48 hr after transfection) to identif y transfected neurons; such neurons responded with large ATP-evoked inward currents or membrane depolarizations (Fig. 8C,D) . We next tested the action of IV M (3 M) on ATP-evoked currents in transfected hippocampal neurons, and IVM markedly augmented the ATP-evoked currents in all neurons tested (Fig. 8 E,F ) . These experiments provide direct evidence that IV M can modulate P2X 4 channels when expressed in neurons and allow unambiguous interpretation of the data showing little effect of IV M on neurons in hippocampal slices (see above and Fig. 7 ).
DISCUSSION
The main finding of the present study is that IV M can augment ATP-evoked currents at homomeric P2X 4 channels, and possibly P2X 4 /P2X 6 channels, by an allosteric mechanism. Table showing reversal potentials for control and IV M-potentiated I 1 in both Na ϩ and NMDG ϩ solutions, as well as the ratio of NMDG ϩ to Na ϩ permeability (n ϭ 5). The NMDG ϩ reversal potential for I 2 is typically Ϫ30 mV (K hakh et al., 1999) .
Functional sequelae of P2X 4 channel allosterism
IVM is an agonist at glutamate-gated chloride channels of invertebrates (Cully et al., 1994) and is a positive allosteric effector of GABA A and ␣7 nicotinic channels (Krusek and Z emkova, 1994; Krause et al., 1998) . These ligand-gated channels all belong to the four transmembrane domains per subunit superfamily (Krusek and Z emkova, 1994; Krause et al., 1998) . In contrast, the P2X channels are unrelated to these channels both at the level of amino acid sequence and protein topology (North, 1996) . At present the binding site for IV M on any ion channel is unknown; sequence comparisons among P2X 4 channels, glutamate-gated chloride channels, or ␣ 7 nicotinic channels reveal no real clues. Nevertheless, IV M is most likely acting on P2X 4 channels themselves and not on components that are endogenous to oocytes, such as calcium-activated chloride channels, for two reasons. First, the effect of IV M was specific to P2X 4 and possibly P2X 4 / P2X 6 channels; P2X 2 , P2X 3 , P2X 2 / P2X 3 , or P2X 7 channels were unaffected, although these channels are also calcium-permeable.
The evidence for potentiation of P2X 4 / P2X 6 channels is not decisive. Second, the kinetics and degree of potentiation for IVM were similar in oocytes, H EK-293 cells, and embryonic hippocampal neurons, clearly demonstrating that the effect of IVM is independent of the host cell in which P2X 4 channels are expressed. The present results demonstrate that IV M specifically increases ATP-evoked currents mediated by P2X 4 channels and suggest that P2X 4 channels contain an allosteric binding site for IVM. IVM does not markedly affect ATP-evoked currents mediated by other P2X subunits expressed in oocytes, such as the P2X 2 channels, which are found in the central and peripheral nervous systems (for review, see Ralevic and Burnstock, 1998) , P2X 3 channels, which are abundant in pain sensors (Chen et al., 1995; Lewis et al., 1995; Cook et al., 1997) , or P2X 7 channels, which are found in immune cells (Nuttle and Dubyak, 1994; Surprenant et al., 1996; Collo et al., 1997) . Thus, IVM may be a useful pharmacological tool that can discriminate central P2X 4 from other P2X channels. Previously, radioligand-binding studies have suggested that ATP binding to P2X 4 channels can be modulated allosterically (Michel et al., 1997) . By using IVM we (1) identify a novel chemical structure that specifically probes P2X 4 channels, (2) characterize the effects of this modulation on the properties of P2X 4 channels, and (3) show that P2X 4 channel modulation by IVM is by an allosteric mechanism. In agreement with published functional studies that show suramin to be ineffective at P2X 4 channels Seguela et al., 1996; Soto et al., 1996) , we find no evidence to show that suramin can modulate P2X 4 channel currents.
An allosteric action of IVM on P2X 4 is supported by the observations that IVM rarely produced a change in the holding current by itself but potentiated the current evoked by ATP and ϭ 3) , whereas the scatter graph shows data for nonresponding CA1 neurons (E), the three responding neurons (f; arrows), and the average for all 13 neurons (F). slowed its deactivation. The ATP analog ␣,␤-methylene-ATP is a weak agonist at P2X 4 channels and evokes ϳ10% of the current evoked by ATP at similar concentrations. Interestingly, however, ␣,␤-methylene-ATP and ATP both bind with relatively high affinity to P2X 4 channels (Michel et al., 1997) , suggesting that the low-potency ␣,␤-methylene-ATP in functional experiments may be attributable to a lower intrinsic efficacy or a lower ability to gate the channel once bound. In the presence of IVM, ␣,␤-methylene-ATP becomes a potent agonist, another familiar property of allosteric effectors. If f urther experiments lead to knowledge about the binding site and mechanisms of allosterism by IV M, this will be a usef ul approach to study the events leading to P2X channel gating after ATP binding.
Responses in neurons
Having established the specificity of IV M as an allosteric effector of P2X 4 channels in oocytes, H EK cells, and embryonic hippocampal neurons, we next tested its actions in adult brain neurons that express mRNA transcripts for P2X 4 . Our initial goal was to determine whether homomeric P2X 4 channels are expressed in these neurons. In the brainstem M N V we found that IVM did not affect ATP-evoked currents, and this is consistent with previous conclusions that the P2X channels in M N V neurons are most like P2X 5 (Cook et al., 1997) or a combination of P2X channels (Khakh et al., 1997) . The CA1 field of the hippocampus is abundant in P2X 4 mRNA, and previous investigators therefore suggested that homomeric P2X 4 channels might be expressed in these cells Collo et al., 1996) . To our surprise, IVM did not affect ATP-evoked currents in these neurons, suggesting that homomeric P2X 4 channels are not located on the soma of pyramidal cells, but functional activity of these channels on the dendrites was not tested. To the extent that our data suggest that heteromeric P2X 4 /P2X 6 channels are also potentiated by IVM, we may conclude that such channels are also not expressed in these cells. It is possible that the endogenous P2X channels in CA1 comprise (1) other heteromeric P2X channels, (2) a mixed population of P2X channels, or (3) a new P2X channel and/or (4) that homomeric P2X 4 channels are found in only a subset of CA1 neurons. The marked enhancement of responses in a small fraction of hippocampal neurons (Fig. 7F ) is consistent with this last conclusion, but further studies are needed to discriminate between these four possibilities. Known heteromeric P2X channel assemblies are activated by ␣,␤-methylene-ATP, and it has been proposed that they may constitute some of the P2X channels found in the CNS, possibly including those in the hippocampus (Le et al., 1998a; Torres et al., 1998 Torres et al., , 1999 . This proposal is supported by data showing overlapping distribution of many P2X subunit mRNAs throughout the nervous system . Interestingly, recent data from the CA1 region of the hippocampus also show that the P2X channels can be activated by ␣,␤-methylene-ATP (this study) and partially blocked by antagonists (Pankratov et al., 1998; Proctor and Dunwiddie, 1998) . These properties, along with the insensitivity to IV M, suggest that the predominant ATP-evoked current (Pankratov et al., 1998) in the CA1 of the hippocampus is mediated by neither homomeric P2X 4 nor heteromeric P2X 4 / P2X 6 channels but rather by channels with properties that may be most similar to those described for other heteromeric channels (Lewis et al., 1995; Le et al., 1998a; Torres et al., 1998 Torres et al., , 1999 . The P2X 4 message is not restricted to the hippocampus and is found in many brain areas ; it remains to be determined whether some of these neuron subsets do indeed express homomeric P2X 4 channels.
Allosteric modulators of other ligand-gated ion channels have become important experimental tools to determine the contribution of distinct channel types to the f unction of brain synapses. P2X 2 and P2X 3 receptors are modulated by cations such as Zn 2ϩ , H ϩ , and C a 2ϩ
, and it is possible that such modulation has a physiological role as well Stoop et al., 1997; Wildman et al., 1997 Wildman et al., , 1998 Cook et al., 1998) . The lack of pharmacological probes for P2X 4 channels has hindered understanding of their f unction, but in the present study we have identified IV M as the first agent that discriminates P2X 4 from other P2X channels. Remarkably, IV M can increase the gating efficiency and slow the deactivation kinetics of ATP at P2X 4 channels, suggesting that the open probabilities of P2X 4 channels increase in the presence of IV M. Overall IV M evokes a profound gain-of-f unction phenotype in P2X 4 channels. It remains to be determined whether the site on the P2X 4 protein that IVM probes is also the target for an endogenous allosteric effector.
